Search

Your search keyword '"Thomas Kielsgaard Kristensen"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Thomas Kielsgaard Kristensen" Remove constraint Author: "Thomas Kielsgaard Kristensen" Language undetermined Remove constraint Language: undetermined
48 results on '"Thomas Kielsgaard Kristensen"'

Search Results

2. Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC

3. Impaired immune responses to herpesviruses and microbial ligands in patients with Mono <scp>MAC</scp>

4. Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis

5. Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations

6. Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma

7. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC)

8. Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study

9. Erratum to 'Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma' [Experimental Hematology 84 (2020) 7–18]

10. Fatal anaphylaxis following a hornet sting in a yellow jacket venom-sensitized patient with undetected monoclonal mast cell activation syndrome and without previous history of a systemic sting reaction

11. Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)

12. Targeted ultradeep next-generation sequencing as a method forKITD816V mutation analysis in mastocytosis

13. Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosis

14. A child with mastocytosis and lymphomatoid papulosis

15. Venom anaphylaxis can mimic other serious conditions and disclose important underlying disease

16. Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next-Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia

17. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

18. SensitiveKITD816V mutation analysis of blood as a diagnostic test in mastocytosis

19. Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

20. KIT D816V Mutation-Positive Cell Fractions in Lesional Skin Biopsies from Adults with Systemic Mastocytosis

21. Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study

22. [Mastocytosis]

23. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology

24. Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus

25. NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression*

26. Seminal human papillomavirus originates from the body surface and is not a frequent aetiological factor in azoospermia

27. [New disease markers within the chronic myeloproliferative neoplasms]

28. Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations

29. High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia

30. Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient

31. Epidemiology of systemic mastocytosis in Denmark

32. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate

33. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis

34. Low incidence of minor BRAF V600 mutation-positive subclones in primary and metastatic melanoma determined by sensitive and quantitative real-time PCR

35. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis

36. Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia

37. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay

38. Relapse of myeloid neoplasm with eosinophilia andPDGFRArearrangement after imatinib discontinuation in a pediatric patient

39. Anaphylaxis caused by mosquito allergy in systemic mastocytosis

40. Mutation in the Nucleophosmin Gene (NPM1) Is a Stable Marker for Minimal Residual Disease Monitoring in Acute Myeloid Leukemia Patients with Increased Sensitivity and Specificity Compared to Expression of the Wilms Tumor (WT1) Gene

41. 1151 POSTER Fatigue in cancer patients at the time of rehabilitation

42. 8175 POSTER Side effects at the time of rehabilitation as reported by more than 600 cancer patients in response to an open question and a structered, closed questionaire

45. Molecular heterogeneity of mantle cell lymphoma

46. Systemic mastocytosis--a systematic review

48. Nye sygdomsmarkører ved de kroniske myeloproliferative neoplasier

Catalog

Books, media, physical & digital resources